Anthracyclines inhibit SARS-CoV-2 infection

Anthracyclines inhibit SARS-CoV-2 infection

Vaccines and drugs are two effective medical interventions to mitigate SARS-CoV-2 infection. Three SARS-CoV-2 inhibitors, remdesivir, paxlovid, and molnupiravir, have been approved for treating COVID-19 patients, but more are needed, because each drug has its limitation of usage and SARS-CoV-2 const...

Full description

Bibliographic Details
Main Authors: Zhen Wang, Qinghua Pan, Ling Ma, Jianyuan Zhao, Fiona McIntosh, Zhenlong Liu, Shilei Ding, Rongtuan Lin, Shan Cen, Andrés Finzi, Chen Liang
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Virus Research
Subjects:
SARS-CoV-2
Microbial metabolites
Anthracycline
Interferon
Online Access:http://www.sciencedirect.com/science/article/pii/S0168170223001260

Internet

http://www.sciencedirect.com/science/article/pii/S0168170223001260

Similar Items